PT  - JOURNAL ARTICLE
AU  - Banda, Juan M.
AU  - Adderley, Nicola
AU  - Ahmed, Waheed-Ul-Rahman
AU  - AlGhoul, Heba
AU  - Alser, Osaid
AU  - Alser, Muath
AU  - Areia, Carlos
AU  - Cogenur, Mikail
AU  - Fišter, Krisitina
AU  - Gombar, Saurabh
AU  - Huser, Vojtech
AU  - Jonnagaddala, Jitendra
AU  - Lai, Lana YH
AU  - Leis, Angela
AU  - Mateu, Lourdes
AU  - Mayer, Miguel Angel
AU  - Minty, Evan
AU  - Morales, Daniel
AU  - Natarajan, Karthik
AU  - Paredes, Roger
AU  - Periyakoil, Vyjeyanthi S.
AU  - Prats-Uribe, Albert
AU  - Ross, Elsie G.
AU  - Singh, Gurdas
AU  - Subbian, Vignesh
AU  - Vivekanantham, Arani
AU  - Prieto-Alhambra, Daniel
TI  - Characterization of long-term patient-reported symptoms of COVID-19: an analysis of social media data
AID  - 10.1101/2021.07.13.21260449
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.07.13.21260449
4099  - http://medrxiv.org/content/early/2021/07/15/2021.07.13.21260449.short
4100  - http://medrxiv.org/content/early/2021/07/15/2021.07.13.21260449.full
AB  - As the SARS-CoV-2 virus (COVID-19) continues to affect people across the globe, there is limited understanding of the long term implications for infected patients1–3. While some of these patients have documented follow-ups on clinical records, or participate in longitudinal surveys, these datasets are usually designed by clinicians, and not granular enough to understand the natural history or patient experiences of ‘long COVID’. In order to get a complete picture, there is a need to use patient generated data to track the long-term impact of COVID-19 on recovered patients in real time. There is a growing need to meticulously characterize these patients’ experiences, from infection to months post-infection, and with highly granular patient generated data rather than clinician narratives. In this work, we present a longitudinal characterization of post-COVID-19 symptoms using social media data from Twitter. Using a combination of machine learning, natural language processing techniques, and clinician reviews, we mined 296,154 tweets to characterize the post-acute infection course of the disease, creating detailed timelines of symptoms and conditions, and analyzing their symptomatology during a period of over 150 days.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJMB was funded by a grant by the National Institute of Aging (3P30AG059307-02S1). DPA is funded through an NIHR Senior Research Fellowship (Grant number SRF-2018-11-ST2-004). VH contribution to this work was carried out with support from National Library of Medicine, National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB not neededAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available after formal publication.